Healthcare provider profile · identity verified

Douglas Walter Chudzik, MD

Internal Medicine · HAZLET, NJ · NPI 1477586931

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	245	58
Amlodipine Besylate	Amlodipine Besylate	211	58
Montelukast Sodium	Montelukast Sodium	199	51
Atorvastatin Calcium	Atorvastatin Calcium	177	56
Metoprolol Succinate	Metoprolol Succinate	144	33
Alprazolam	Alprazolam	126	32
Omeprazole	Omeprazole	126	35
Pantoprazole Sodium	Pantoprazole Sodium	114	29
Metformin Hcl	Metformin Hcl	111	30
Furosemide	Furosemide	103	29
Fluticasone Propionate	Fluticasone Propionate	85	41
Potassium Chloride	Potassium Chloride	84	25
Enalapril Maleate	Enalapril Maleate	81	23
Hydrochlorothiazide	Hydrochlorothiazide	77	19
Gabapentin	Gabapentin	64	15
Losartan Potassium	Losartan Potassium	58	15
Clopidogrel	Clopidogrel Bisulfate	56	13
Trazodone Hcl	Trazodone Hcl	54	17
Lisinopril	Lisinopril	53	13
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	11
Sucralfate	Sucralfate	49	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	45	suppressed
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	15
Mounjaro	Tirzepatide	43	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	41	15
Januvia	Sitagliptin Phosphate	40	12
Tramadol Hcl	Tramadol Hcl	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	14
Famotidine	Famotidine	38	suppressed
Ezetimibe	Ezetimibe	37	suppressed
Meloxicam	Meloxicam	33	suppressed
Sertraline Hcl	Sertraline Hcl	32	11
Tamsulosin Hcl	Tamsulosin Hcl	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Eliquis	Apixaban	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	12
Raloxifene Hcl	Raloxifene Hcl	28	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Lorazepam	Lorazepam	26	suppressed
Ozempic	Semaglutide	26	suppressed
Carisoprodol	Carisoprodol	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	23	suppressed
Nateglinide	Nateglinide	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Allopurinol	Allopurinol	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Prednisone	Prednisone	20	12
Clonazepam	Clonazepam	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Simvastatin	Simvastatin	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Celecoxib	Celecoxib	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Levofloxacin	Levofloxacin	14	12
Oxycontin	Oxycodone Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Baclofen	Baclofen	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Azithromycin	Azithromycin	12	11
Diazepam	Diazepam	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Ramipril	Ramipril	12	suppressed
Topiramate	Topiramate	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error